SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-299679
Filing Date
2017-09-29
Accepted
2017-09-29 16:53:56
Documents
2
Group Members
AMIR NASHATJONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d443408dsc13da.htm SC 13D/A 143337
2 EX-99.A d443408dex99a.htm EX-99.A 13772
  Complete submission text file 0001193125-17-299679.txt   158940
Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Subject) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89550 | Film No.: 171112082
SIC: 2834 Pharmaceutical Preparations